11-hydroxyandrostenedione

Subscribe to Selected New Research on 11-hydroxyandrostenedione

10 relevant articles (1 outcomes, 0 trials/studies) found for this Bio-Agent

Description: RN given refers to cpd without isomeric designation

Also Known As:

11 beta-hydroxyandrostenedione; 11-hydroxy-4-androstene-3,17-dione; 11-hydroxyandrostenedione, (11alpha)-isomer; 11-hydroxyandrostenedione, (11beta)-isomer; 11-hydroxyandrostenedione, (9beta,10alpha,11alpha)-isomer; 11-hydroxyandrostenedione, (9beta,10alpha,11beta)-isomer; 11 beta-hydroxyandrost-4-ene-3,17-dione

Relationship Network

Bio-Agent Context: Research Results

Related Diseases

1.	Hyperandrogenism 12/01/1991 - "However, 11 beta-hydroxyandrostenedione and dehydroepiandrosterone sulfate levels did not correlate in either the women with hyperandrogenism (r = 0.12) or the 26 normal women (r = 0.29)" 07/01/1992 - "OBJECTIVE: To determine if the ratio of serum androstenedione (A):11 beta-hydroxyandrostenedione (OHA) would be helpful in differentiating adrenal from ovarian hyperandrogenism" 12/01/1991 - "To determine whether the adrenal androgen 11 beta-hydroxyandrostenedione is a more sensitive and specific marker than dehydroepiandrosterone sulfate, we compared these serum androgens in 81 women with anovulatory hyperandrogenism before treatment, after corticotropin and corticotropin-releasing-factor stimulation, and after short- and long-term dexamethasone suppression" Get all the results and reference details, order at left...
2.	Varicocele 01/01/1992 - "Higher levels of an exclusively adrenal androgen 11 beta-hydroxyandrostenedione in men with varicocele indicate increased activity of the adrenal cortex" Get all the results and reference details, order at left...
3.	Syndrome 10/01/1992 - "OBJECTIVE: To investigate the role of 11 beta-hydroxylase/11 beta-hydroxyandrostenedione (11-OHA) in the ovarian metabolism of androgens in women with polycystic ovaries (PCO) and its associated syndrome (PCOS)" Get all the results and reference details, order at left...
4.	Pseudohermaphroditism 07/01/1985 - "To investigate the enzymatic basis for abnormal steroid metabolism in subjects with male pseudohermaphroditism due to 5 alpha-reductase deficiency, the ring A reduced urinary 5 beta and 5 alpha metabolites of testosterone, androstenedione, 11 beta-hydroxyandrostenedione, cortisol and corticosterone were measured by gas chromatography" Get all the results and reference details, order at left...
5.	Neoplasms (Cancer) 11/01/1991 - "The presence of specific 11 beta-hydroxylated steroids (11 beta-hydroxyandrostenedione, 21-deoxycortisol, and 21-deoxycorticosterone) in the gonadal vein demonstrated the adrenal nature of the testicular tumor" Get all the results and reference details, order at left...
9 Diseases and 10 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Androstenedione (4 Androstene 3,17 dione)
2.	DoVA protocol
3.	Testosterone (Sustanon)
4.	Hydrocortisone (Cortisol)
5.	Dexamethasone (Maxidex)
6.	Dehydroepiandrosterone (DHEA)
7.	Androgens
8.	Cholestenone 5 alpha-Reductase (5 alpha-Reductase)
9.	17-alpha-Hydroxyprogesterone (17 Hydroxyprogesterone)
10.	Dehydroepiandrosterone Sulfate
17 Drugs and Important Bio-Agents and 8 more articles analyzed in the Research Interface, order at left...

Research Interface Subscription

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Searches
2 clicks from Disease to Drug to Evidence
Trial references
All the Positive Outcomes
Drug and Therapy searches
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface Subscription

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>